EGFR and central nervous system cancer: Utilizing pathway information from DAVID, we found that the subnet with EGFR as a target gene was highly enriched with glioma genes (p<0.004), the MAPK signaling pathway (p<0.02), and pathways in cancer in general (p<8×10−8).